Thought Leadership
The following is a selection of thought leadership from Goodwin's Private Equity M&A team on happenings in the market:
Take Privates: Our US and European M&A Partners discuss the uptick in takeover activity and the pitfalls that PE buyers need to navigate in these deals. Watch the video below.
Equity Rollovers: We explore the growing use of equity rollovers in private equity transactions to facilitate deal continuity and align interests between stakeholders.
M&A Buyouts vs. Growth Equity Transactions: As buyout funds increasingly look to expand their portfolio into growth equity strategies and minority investments, we explore the structural nuances, risk considerations, and strategic objectives inherent in varying transaction structures.
Equity Freeze: We consider an alternative solution for dealing with the equity interests of departing employees which eliminates the need for immediate liquidity.
Incentive Equity Vesting: We take a look at the evolving trends in incentive structures, including how vesting criteria are adapting to meet the challenges of a dynamic investment landscape.
Deal Type Statistics
What We Accomplished
In 2024, our team achieved the following milestones:
Awards & Accolades
Select Private Equity Deal Highlights
Advised McWin Capital Partners on its acquisition of Sticks’n’Sushi, a popular restaurant chain with multiple locations across Europe.
Advised H.I.G. Capital on its acquisition of Sleepeezee, a UK-based producer of bespoke and luxury beds and mattresses, and its combination with existing portfolio company, Silentnight, under a new identity as The Sleep Group.
Advised TA Associates on its agreement to make a strategic growth investment in SER, a leading global Intelligent Content Automation software vendor in the enterprise content management market.
Advised Templewater and its portfolio company TW Pengu Holdings, on their acquisitions of numerous healthcare assets including: Singapore Breast Surgery Center, Central Luzon and Can-Care.
Advised FountainVest on the $1.37 billion IPO of its portfolio company, Amer Sports, a global group of iconic sports and outdoor brands.
Advised Eurazeo on the sale and reinvestment in EFESO Management Consultants, a leading international pure player consulting group in industrial operations strategy and performance improvement, alongside TowerBrook Capital Partners.
Advised Novo Holdings on its take-private acquisition of Catalent, a CDMO partner delivery technologies and manufacturing solutions to pharmaceuticals, biologics, and consumer health products.
Advised InTandem Capital Partners on its investment in Adams Clinical, a renowned clinical trial site network that conducts independent evaluations of drugs to treat psychiatric and neurologic illnesses.
Advised TowerBrook Capital Partners in its majority equity investment in LiftWerx Holdings Inc., a Canada-based operations and maintenance services provider to the onshore wind industry.